116 related articles for article (PubMed ID: 6091230)
1. [Problems posed by the preparation of specific anti-cytomegalovirus immunoglobulins].
Streiff F; Janot C; Briquel ME; Stoltz JF
Rev Fr Transfus Immunohematol; 1984 Jun; 27(3):383-9. PubMed ID: 6091230
[TBL] [Abstract][Full Text] [Related]
2. [Preparation of a specific anti-cytomegalovirus immunoglobulin for intravenous injection].
Maniez-Montreuil M; Dupressoir-Burlet MV; Martinache L; Goudemand M
Rev Fr Transfus Immunohematol; 1984 Jun; 27(3):375-82. PubMed ID: 6091229
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus (CMV) antibody in male homosexuals: a source for CMV immune globulin.
Ikram H; Prince AM; Baker LN
Vox Sang; 1983 Mar; 44(3):173-7. PubMed ID: 6301160
[TBL] [Abstract][Full Text] [Related]
4. [Immunological diagnosis of cytomegalovirus infections. Application to blood transfusion centers].
Aymard M; Tardy JC; Gibert R
Rev Fr Transfus Immunohematol; 1984 Jun; 27(3):309-21. PubMed ID: 6091222
[TBL] [Abstract][Full Text] [Related]
5. Selection of an intravenous immune globulin for the immunoprophylaxis of cytomegalovirus infections: an in vitro comparison of currently available and previously effective immune globulins.
Chehimi J; Peppard J; Emanuel D
Bone Marrow Transplant; 1987 Dec; 2(4):395-402. PubMed ID: 2844341
[TBL] [Abstract][Full Text] [Related]
6. Circulating cytomegalovirus (CMV) neutralizing activity in bone marrow transplant recipients: comparison of passive immunity in a randomized study of four intravenous IgG products administered to CMV-seronegative patients.
Filipovich AH; Peltier MH; Bechtel MK; Dirksen CL; Strauss SA; Englund JA
Blood; 1992 Nov; 80(10):2656-60. PubMed ID: 1330079
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations.
Planitzer CB; Saemann MD; Gajek H; Farcet MR; Kreil TR
Transplantation; 2011 Aug; 92(3):267-70. PubMed ID: 21659947
[TBL] [Abstract][Full Text] [Related]
8. [Specific anti-cytomegalovirus immunoglobulins in the prevention of cytomegalovirus infections in bone marrow allografts].
Huart JJ; Baume D; Jouet JP
Ann Med Interne (Paris); 1987; 138(5):372-4. PubMed ID: 2823667
[TBL] [Abstract][Full Text] [Related]
9. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients.
Snydman DR; Werner BG; Heinze-Lacey B; Berardi VP; Tilney NL; Kirkman RL; Milford EL; Cho SI; Bush HL; Levey AS
N Engl J Med; 1987 Oct; 317(17):1049-54. PubMed ID: 2821397
[TBL] [Abstract][Full Text] [Related]
10. Determination of cytomegalovirus antibody titers in sera of volunteer blood donors by use of complement fixation and two immunoenzymatic tests.
Dzierzanowska D; Kołodziejczyk J; Lourie I
Arch Immunol Ther Exp (Warsz); 1986; 34(4):397-402. PubMed ID: 3026277
[TBL] [Abstract][Full Text] [Related]
11. [Clinical use of immunoglobulin titers of anti-cytomegalovirus antibodies].
Pouteil-Noble C; Touraine JL; Gibert R; Aymard M
Rev Fr Transfus Immunohematol; 1984 Jun; 27(3):365-74. PubMed ID: 6091228
[TBL] [Abstract][Full Text] [Related]
12. Hyperimmune globulin in pregnancy for the prevention of congenital cytomegalovirus disease.
Nigro G
Expert Rev Anti Infect Ther; 2017 Nov; 15(11):977-986. PubMed ID: 29072089
[TBL] [Abstract][Full Text] [Related]
13. Binding and neutralizing anti-cytomegalovirus activities in immune globulin products.
Wang X; Xu Y; Scott DE; Murata H; Struble EB
Biologicals; 2017 Nov; 50():35-41. PubMed ID: 29029807
[TBL] [Abstract][Full Text] [Related]
14. Functional Properties of Human Cytomegalovirus Hyperimmunoglobulin and Standard Immunoglobulin Preparations.
Germer M; Herbener P; Schüttrumpf J
Ann Transplant; 2016 Sep; 21():558-64. PubMed ID: 27595792
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of cytomegalovirus-specific hyperimmune globulins vs. standard intravenous immunoglobulins.
Miescher SM; Huber TM; Kühne M; Lieby P; Snydman DR; Vensak JL; Berger M
Vox Sang; 2015 Jul; 109(1):71-8. PubMed ID: 25766313
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease.
Snydman DR
Rev Infect Dis; 1990; 12 Suppl 7():S839-48. PubMed ID: 2173113
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of CMV ELISA antibody: titer and neutralizing activity in intramuscular immune globulin of placental origin.
Gibert R; el Habib R; Allard JP; Defayolle M; Aymard M
Transplant Proc; 1987 Oct; 19(5):4083-6. PubMed ID: 2823436
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus seronegative heart transplant recipients. Prophylactic use of anti-CMV immunoglobulin.
Metselaar HJ; Balk AH; Mochtar B; Rothbarth PH; Weimar W
Chest; 1990 Feb; 97(2):396-9. PubMed ID: 2153508
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B immune globulin as treatment of CMV infections in patients with AIDS.
Jordan WC
J Natl Med Assoc; 1986 Jan; 78(1):61-2. PubMed ID: 3005599
[TBL] [Abstract][Full Text] [Related]
20. Use of intravenous immune globulin in patients receiving bone marrow transplants.
Winston DJ; Ho WG; Rasmussen LE; Lin CH; Chu HL; Merigan TC; Gale RP
J Clin Immunol; 1982 Apr; 2(2 Suppl):42S-47S. PubMed ID: 6282926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
